ACTOFERRIN PREVENTION OF NEONATAL SEPSIS

IVERSIDAD PERUANA CAYETANO HEREDIA,0 个研究点目标入组 414 人开始时间: 2011年12月27日最近更新: 2023年9月4日

试验速览

暂无简介。

•1.NEONATES WITH BIRTH WEIGHT BETWEEN 500G and 2000G AT BIRTH TIME.
•2. NEONATES BORN IN OR REFERRED TO, THE INTENSIVE OR INTERMEDIATE CARE UNIT OF NEONATOLOGY OF PARTICIPATING HOSPITALS BEFORE MENTIONED, IN THE FIRST 72 HOURS OF LIFE.

•1. NEONATES WITH UNDERLYING GASTROINTESTINAL PROBLEMS THAT MAKES IMPOSSIBLE ORAL ROUTE.
•2. NEONATES WITH UNDERLYING CONDITIONS DEEPLY AFFECTING GROWTH AND DEVELOPMENT (CHROMOSOMAL ABNORMALITIES, STRUCTURAL BRAIN ABNORMALITIES, SEVERE CONGENITAL ABNORMALITIES).
•3. NEONATES WITH A FAMILIAR HISTORY OF ALLERGY TO COW´S MILK.
•4. ANY NEONATE THAT IN AGREEMENT WITH THE RESEARCHER´S CRITERIA DON´T HAVE THE POSSIBILITY TO COMPLETE THE STUDY MONITORING VISITS (PATIENT THAT BEFORE TWO MONTHS OF AGE MUST RETURN TO PROVINCE).
•5. NEONATES WHOSE PARENTS DO NOT WANT TO PARTICIPATE.

发起方

IVERSIDAD PERUANA CAYETANO HEREDIA,